Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-06-27
2010-06-01
Gupta, Anish (Department: 1654)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
07727719
ABSTRACT:
The present invention provides compositions and methods for research, diagnostic, drug screening, and therapeutic applications related to paroxysmal dystonic choreoathetosis and related conditions. In particular, the present invention provides mutations in the myofibrillogenesis regulator 1 (MR-1) gene associated with such conditions.
REFERENCES:
Li et al., Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle, Jun. 22, 2004, Acta Biochimica et Biophysica Sinica, 36(6):412-418.
Muller et al., Clinical and molecular genetics of primary dystonias, 1998, Neurogenetics, 1:165-177.
Web site http://dictionary.reference.com/browse/diagnostic accessed Apr. 30, 2008, 1 page.
Lee et al, Human Molecular Genetics, 2004 v13 pp. 3161-3170.
Rainier et al, Arch Neurol, 2004, pp. 1025-1029.
Partridge et al, Journal of Cereal Science,2002, v35 pp. 189-200.
Skvortsova et al (European Journal of Human Genetics v12 2004 pp. 241-244).
Fink et al., “Paroxysmal dystonic choreoathetosis: tight linkage to chromosome 2q,” Am J Hum Genet. 1996, 59:140-145.
Fouad et al., “A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q.,” Am J Hum Genet. 1996, 59:135-139.
Jarman et al., “Paroxysmal dystonic choreoathetosis. Genetic linkage studies in a British family,” Brain. 1997, 120:2125-2130.
Matsuo et al., “Familial paroxysmal dystonic choreoathetosis: clinical findings in a large Japanese family and genetic linkage to 2q,” Arch Neurol. 1999, 56:721-726.
Hofele et al., “Gene locus FPD1 of the dystonic Mount-Reback type of autosomal-dominant paroxysmal choreoathetosis,” Neurology. 1997, 49:1252-1257.
Przuntek et al., “TTherapeutic aspects of kinesiogenic paroxysmal choreoathetosis and familial paroxysmal choreoathetosis of the Mount and Reback type,” J Neurol. 1983, 230:163-169.
Raskind et al., “Further localization of a gene for paroxysmal dystonic choreoathetosis to a 5-cM region on chromosome 2q34,” Hum Genet. 1998, 102:93-97.
Bohnen et al., “(+)-alpha-[11C]Dihydrotetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis,” Neurology. 1999, 52:1067-1069.
Grunder et al., “Acid-sensing ion channel (ASIC) 4 gene: physical mapping, genomic organisation, and evaluation as a candidate for paroxysmal dystonia,” Eur J Hum Genet. 2001, 9:672-676.
Tokarz D., et al., “Mutation analysis of two candidate genes in the paroxysmal dystonic choreoathetosis locus on chromosome 2q,” Am J Hum Genet. 2001, 69:629.
Rainier et al., “NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6),” AmJ Hum Genet. 2003, 73:967-971.
Zhao et al., “Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia,”Nat Genet. 2001, 29:326-331.
Fink et al., “Paroxysmal dystonic choreoathetosis linked to chromosome 2q: clinical analysis and proposed pathophysiology.,” Neurology. 1997, 49:177-183.
Fink John K.
Rainier Shirley
Casimir Jones SC
Gupta Anish
Niebauer Ronald T
The Regents of the University of Michigan
LandOfFree
Methods for diagnosing episodic movement disorders and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for diagnosing episodic movement disorders and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosing episodic movement disorders and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4153465